NCT01072214View on ClinicalTrials.gov

A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

March 9, 2010

Primary Completion Date

June 28, 2010

Study Completion Date

June 28, 2010

Conditions

Macular Degeneration

Interventions

DRUG

pazopanib

gw786034

DRUG

pazopanib

gw786034

DRUG

pazopanib

gw786034

DRUG

Placebo

placebo

Trial Locations (1)

91206

GSK Investigational Site, Glendale

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01072214 - A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers | Biotech Hunter | Biotech Hunter